MedTrace Logo

Coronary Artery Disease and Renal Failure Registry

NCT00679419 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3352

Last updated 2012-11-02

No results posted yet for this study

Summary

It is the aim of the multi-centric and prospective registry to analyze in patients with CAD the impact of different grades of renal failure on the outcome and course of the patients and to correlate these with clinical variables.

In particular, the registry has the following objectives:

* prospective consecutive assessment of all patients with coronary artery disease and renal failure in the participating hospitals of the registry
* evaluation of the outcome and course of patients with regard to their different stages of renal failure at baseline
* analysis of the impact of different therapeutic strategies on acute and long-term outcomes
* identification of clinical risk factors, novel biomarkers and genetic markers for an unfavorable long-term outcome

Conditions

Sponsors & Collaborators

  • BMBf (Federal Ministry of Education and Research)

    collaborator UNKNOWN

  • KfH Kuratorium für Dialyse und Nierentransplantation e.V.

    collaborator UNKNOWN

  • Amgen

    collaborator INDUSTRY

  • AstraZeneca

    collaborator INDUSTRY

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Sanofi

    collaborator INDUSTRY

  • Institut für Klinisch-Kardiovaskuläre Forschung GmbH

    lead NETWORK

Principal Investigators

  • Eva Brand, Prof. Dr. · University Hospital of Muenster

  • Holger Reinecke, Prof. Dr. · University Hospital of Muenster

  • Günter Breithardt, Prof. Dr. · University Hospital of Muenster

  • Hermann Pavenstädt, Prof. Dr. · University Hospital of Muenster

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2011-05-31
Completion
2013-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679419 on ClinicalTrials.gov